An investigation on behalf of investors in Pardes Biosciences, Inc. (NASDAQ:PRDS) shares over potential wrongdoing at Pardes Biosciences, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 02/14/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Pardes Biosciences, Inc.
Investors who purchased shares of Pardes Biosciences, Inc. (NASDAQ: PRDS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Pardes Biosciences directors breached their fiduciary duties and caused damage to the company and its shareholders.
Carlsbad, CA based Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease.
On December 23, 2021, Pardes Biosciences, Inc. entered into a definitive merger agreement to acquire FS Development Corp. II (NasdaqCM:FSII) from FS Development Holdings II, LLC, Daniel Dubin, Owen Hughes, Deepa Pakianathan, and others for approximately $320 million in a reverse merger transaction on June 29, 2021.
Shares of Pardes Biosciences, Inc. (NASDAQ: PRDS) declined to as low as $0.75 per share on November 29, 2022.
On January 19, 2023, NASDAQ: PRDS shares closed at $1.76 per share.
Those who purchased shares of Pardes Biosciences, Inc. (NASDAQ: PRDS) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.